Aarti Drugs (AARTIDRUGS) | Stock Overview & Key Data
Aarti Drugs Performance Comparison
Stock Range
Today's Range
Low: ₹505.00
High: ₹522.20
on September 23, 2025
52 Week Range
Low: ₹312.00
High: ₹564.05
on April 7, 2025
on July 21, 2025
All-Time High: ₹1,026.95 on October 5, 2020
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR47.6B
EPS
20.65
P/E Ratio (TTM)
25.19
Forward P/E
16.01
P/B Ratio
3.47
PEG Ratio
0.40
Div. Yield
0.22%
ROE
12.28%
Beta
0.121
Debt to Equity
44.92
Financial Highlights
Profitability
Gross Margin
36.77%
Operating Margin
10.11%
Profit Margin
7.80%
Returns and Earnings
Return on Assets (TTM)
6.53%
Return on Equity (TTM)
12.28%
EBITDA
INR3.2B
Net Income (TTM)
INR1.9B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR265.39
Quarterly Revenue Growth (YoY)
6.30%
Quarterly Earnings Growth (YoY)
62.20%
Dividend Information
Last 12-Month Dividend
₹1.00
Current Dividend Yield
0.22%
3-Year Average Dividend Yield
0.23%
3-Year Average Annual Dividend
₹1.00
3-Year Total Dividends
₹3.00
Ex-Dividend Date
February 4, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Aarti Drugs AARTIDRUGS | 47.58B Small-cap | 1.02% | 7.27% | 19.16% | 44.80% | 13.25% | 0.29% | 10.05% | -36.30% |
| Sun Pharmaceutical SUNPHARMA | 3.94T Large-cap | 1.29% | -1.54% | -1.88% | -8.61% | -13.69% | -16.29% | 71.95% | 221.80% |
| Divi's Laboratories DIVISLAB | 1.63T Large-cap | -0.80% | -3.16% | -8.82% | 2.37% | -0.36% | 10.87% | 63.31% | 97.43% |
| Innova Captab INNOVACAP | 49.75B Small-cap | 0.99% | -6.99% | 2.72% | -7.32% | -21.64% | 12.51% | 60.58% | 60.58% |
| Sequent Scientific SEQUENT | 46.87B Small-cap | 8.94% | 16.35% | 10.31% | 40.43% | 10.17% | -6.38% | 96.64% | 30.36% |
| Sun Pharma Advanced SPARC | 46.74B Small-cap | -3.08% | -3.68% | -11.01% | -10.67% | -30.54% | -34.39% | -36.68% | -19.19% |
Ownership & Short Interest
Insider Ownership
60.36%
Institutional Ownership
10.89%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
250K
Average 90-Day Volume
176K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is AARTIDRUGS's 52-week high and low?
- In the last 52 weeks, Aarti Drugs reached a high of ₹564.05 (on July 21, 2025) and a low of ₹312.00 (on April 7, 2025).
- What is the market cap and P/E ratio for AARTIDRUGS?
- Curious about Aarti Drugs's size and valuation? Its market capitalization stands at 47.58B. When it comes to valuation, the P/E ratio (trailing twelve months) is 25.19, and the forward P/E (looking ahead) is 16.01.
- Does AARTIDRUGS pay dividends? If so, what's the yield?
- Yes, Aarti Drugs is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.22%, and the company has paid an average of ₹1.00 per share annually over the past 3 years.
- Who are Aarti Drugs's main competitors or similar companies to consider before investing?
When looking at Aarti Drugs, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.94T Healthcare Drug Manufacturers - Specialty & Generic -16.29% 71.95% Divi's Laboratories
DIVISLAB1.63T Healthcare Drug Manufacturers - Specialty & Generic 10.87% 63.31% Innova Captab
INNOVACAP49.75B Healthcare Drug Manufacturers - Specialty & Generic 12.51% 60.58% Sequent Scientific
SEQUENT46.87B Healthcare Drug Manufacturers - Specialty & Generic -6.38% 96.64% Sun Pharma Advanced
SPARC46.74B Healthcare Drug Manufacturers - Specialty & Generic -34.39% -36.68% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Aarti Drugs Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Aarti Drugs's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 12.28%, the Debt to Equity ratio from the most recent quarter is 44.92, and its Gross Profit Margin stands at 36.77%.
- What is the recent revenue and earnings growth for AARTIDRUGS?
- Looking at Aarti Drugs's growth, its revenue over the trailing twelve months (TTM) was INR24B. Compared to the same quarter last year (YoY), quarterly revenue grew by 6.30%, and quarterly earnings saw a YoY growth of 62.20%.
- How much of AARTIDRUGS stock is held by insiders and institutions?
- Wondering who owns Aarti Drugs stock? Company insiders (like executives and directors) hold about 60.36% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 10.89%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.